🔗 Share this article

Acclaimed soul vocalist D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic cancer.

“The brilliant light of our family has faded away for us in this life,” his family confirmed. “After a lengthy and brave struggle with cancer, we are deeply saddened to announce that Michael D’Angelo Archer, known to his followers around the globe as D’Angelo, has been called home.”

D’Angelo made a lasting impact on the music industry with his pioneering modern soul style and collaborations with renowned musicians.

He launched his first record, “Brown Sugar,” in 1995 to instant praise. The album reached the fourth spot on Billboard’s Top R&B Albums chart, went platinum later that year, and earned multiple Grammy nominations.

However, it was his second album, “Voodoo,” in 2000 that boosted his music career into the limelight. The record debuted at the top spot on each of the R&B charts and the main album chart. He won two Grammy Awards: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The personal depiction featured the singer, notably bare to his waist, singing straight into the lens.

D’Angelo stepped back from the spotlight after releasing Voodoo and publicly struggled with substance abuse. In 2005, he was involved in a serious vehicle accident that put him in critical condition.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with another top chart entry on the R&B chart and a Grammy for Best R&B Album.

Once more, in his own mysterious fashion, D’Angelo had limited public appearances in the subsequent period.

The musician was scheduled as a headliner for the 2025 music event, but his appearance was called off, citing an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s health in the weeks before his passing, he had reportedly been in the hospital for months and in palliative care for two weeks.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic cancer, one of the deadliest and least preventable forms of the illness, on a gifted artist whose life was ended too soon.

“We are grieved that he can only leave cherished moments with his family, but we are eternally grateful for the legacy of deeply emotional songs he leaves behind,” his kin expressed.

Pancreatic Cancer: Lethal and Difficult to Avoid

Pancreatic cancer impacts the digestive organ, a tiny gland that generates the hormone insulin and is vital in breaking down food, among other functions. The size and location of the organ in the body make it more difficult to identify malignancy.

Even though this cancer makes up only about 3% of malignancy cases annually in the U.S., it is responsible for seven percent of malignancy fatalities.

Almost seventy thousand people will be diagnosed with this condition and roughly 52,000 will die of the disease in the year 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and dismal outcomes. We have limited and poor therapies, and a smaller window to make a meaningful impact on the well-being of people,” said a cancer specialist.

Since this disease rarely causes early symptoms, it’s often diagnosed only once the disease is late-stage. Even when a individual has indicators they are usually vague and may be confused with a several everyday ailments.

“As of yet, there is no good way to detect this malignancy in the initial phases, except for paying attention to physical changes and consulting your doctor if there are unfamiliar signs,” said a health expert.

Common symptoms of pancreatic cancer include:

• abdominal or lower back pain
• weight loss
• yellowing of skin and eyes
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• diarrhea
• excessive hunger or thirst
• feeling sick

At 51 years old, D’Angelo’s demise is an exception, as pancreatic cancer is typically found in adults in the 65 to 75 range. However, numerous malignancies, such as this type, have become more common in younger adults.

“This disease diagnosed prior to fifty is deemed uncommon, yet concerningly, clinicians are noticing a rising count of younger individuals affected by this condition,” commented a specialist.

Family History Affects Disease Probability

Without effective screening tools for this malignancy, professionals emphasized the importance of knowing your relatives’ cancer history. Certain contributing elements, such as tobacco use and obesity also play a role in the onset of this disease.

African Americans have the greatest occurrence of pancreatic cancer in the United States and are most likely to be found to have untreatable disease.

“The first step toward lowering one’s chance of this condition is assessing personal risk factors. People should examine their family history, hereditary factors, and health issues, such as diabetes, long-term pancreas inflammation, or overweight that may raise their vulnerability,” said a medical professional.

Hereditary risk factors are linked to as much as 10% of all this malignancy cases. If someone in your family has had pancreatic cancer, you may want to think about DNA analysis.

“For people with a family history of pancreatic cancer or those carrying high risk DNA changes, checking may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to detect initial alterations in the pancreas,” he clarified.

For those wishing to reduce their risk, lifestyle changes may have an effect. The most effective action you can take to lower your risk of this disease is to stop tobacco use, and if you don’t smoke, stay away altogether.

Excessive drinking is associated with pancreatitis, a risk factor for pancreatic cancer, so reducing or avoiding drinks may assist reduce your risk.

Managing your body mass or losing weight may also help reduce your risk. People with excess weight are 20% more likely to develop pancreatic cancer. Pancreatic cancer also is more frequent in those with diabetes, and reducing weight can also lower the risk of type 2 diabetes.

In spite of pancreatic cancer’s grim outlook, there is reason for optimism.

“We are making progress with treatments and newer combination chemotherapy. There are emerging targeted therapies that are already showing results,” said a specialist.

For many people, however, awareness about this rare but {dev